02142 和鉑醫藥-B
公司資料 - 股權變動
      回購價 累計回購
日期 回購股數 金額 最高 最低 股數* 佔已發行股本(%)
18/11/2024200,000HKD 237,800HKD 1.190HKD 1.1803,660,0000.476
11/11/2024200,000HKD 240,550HKD 1.210HKD 1.2003,460,0000.450
08/11/2024300,000HKD 357,280HKD 1.210HKD 1.1703,260,0000.424
07/11/2024174,000HKD 206,340HKD 1.190HKD 1.1702,960,0000.385
06/11/2024284,000HKD 329,060HKD 1.170HKD 1.1502,786,0000.362
04/11/202490,000HKD 107,840HKD 1.200HKD 1.1902,502,0000.325
01/11/2024132,000HKD 157,750HKD 1.210HKD 1.1802,412,0000.314
31/10/2024100,000HKD 120,640HKD 1.210HKD 1.1902,280,0000.297
30/10/2024200,000HKD 243,570HKD 1.230HKD 1.1902,180,0000.284
29/10/2024100,000HKD 125,290HKD 1.270HKD 1.2401,980,0000.258
24/10/2024168,000HKD 202,140HKD 1.210HKD 1.2001,880,0000.245
10/10/20248,000HKD 10,760HKD 1.350HKD 1.3401,712,0000.223
09/10/202493,000HKD 125,700HKD 1.360HKD 1.3401,704,0000.222
08/10/2024200,000HKD 285,900HKD 1.450HKD 1.4001,611,0000.210
25/09/2024157,000HKD 189,590HKD 1.240HKD 1.1701,411,0000.184
24/09/2024300,000HKD 372,780HKD 1.260HKD 1.2101,254,0000.163
23/09/2024134,000HKD 163,740HKD 1.240HKD 1.190954,0000.124
20/09/202470,000HKD 86,720HKD 1.250HKD 1.230820,0000.107
19/09/2024100,000HKD 124,860HKD 1.260HKD 1.240750,0000.098
17/09/2024100,000HKD 126,090HKD 1.280HKD 1.240650,0000.085
16/09/2024350,000HKD 404,160HKD 1.190HKD 1.110550,0000.072
13/09/202455,000HKD 62,080HKD 1.130HKD 1.120200,0000.026
12/09/202414,000HKD 15,960HKD 1.140HKD 1.140145,0000.019
11/09/2024100,000HKD 108,970HKD 1.090HKD 1.080131,0000.017
10/09/202431,000HKD 34,680HKD 1.120HKD 1.11031,0000.004
20/12/20231,400,000HKD 2,215,000HKD 1.640HKD 1.5401,750,0000.230
19/12/2023350,000HKD 529,000HKD 1.520HKD 1.500350,0000.050
  1   2  
 備註: * 回購股數累積期乃根據決議案授權日而各異,詳情請查閱相關公司公告或通告。
 

Copyright © 2025 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.